ArticleMolecular cancer therapeutics2021

Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations.

Brion W Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.